The EU is a good vaccine man, but somehow looks like a villain

The development of the Covid-19 vaccine is a scientific wonder and provides a way out of a catastrophic pandemic. It is a source of hope in life that returns to something normal. But to the EU, it seems to be a permanent source of embarrassment.

Many times on the issue of vaccines, the EU has found itself on the other side of the debate. That case tends to get stronger over time — at that point there will be a loss of reputation. Proof is difficult.

Procurement was done first. Brussels was too late to sign the contract and did not pay enough attention to securing production capacity to meet the contract.

The European Commission was furious at the failure to buy, especially in Germany. However, if AstraZeneca signed contracts with the EU and the United Kingdom and could not be fulfilled at the same time, the financing was largely successful.

The block will receive a dose of 400m by the end of next month. Germany currently administers about 700,000 jabs daily. The EU should soon be able to inoculate 70% of the adult population from the UK and the US this summer.

When EU anger boiled AstraZeneca delivery omissionThe Commission has introduced export restrictions in countries that have opted to fight Britain and refused to show interrelationships with supply.

This move had little effect in solving AstraZeneca’s production problems, but did a lot to portray the EU as a hoarding attempt to conceal previous procurement errors. Since then, China has become the world’s second largest exporter of vaccines after trying to correct its perceptions.

“They have been largely unfairly labeled as vaccine protection traders,” says Jacob Kierkegaard of the Peterson Institute for International Economics. As European Commission President Ursula von der Leyen is trying to do now, it is much more difficult for the EU to show itself as a “pharmacy to the world.”

“Europe’s long-term interest is to become the world’s largest vaccine producer. The message should be: Look, we’ll leave your supply chain alone. It’s a committee member. It is the interest of Europe that the Society should have clarified from the beginning. “

Then last week, when the Biden administration came out in favor, the EU was on the wrong track. Abandon vaccine patentAs a way to increase supply to poorer countries, despite European opposition.

The EU, which shipped a dose of about the same amount as the domestically administered dose of about 200 m, has been made to look like a villain in the world community. The United States has “lent” millions to Mexico and Canada, but has promised to share up to 60 million doses.

Whether the EU was surprised or couldn’t discourage Washington, it was a diplomatic failure.

EU officials see the US move as a public relations coup to please the Democratic base. French Minister of Europe Clement Beaune described it as “the sparkle of the United States.”

Some EU leaders don’t want to look transient on the issue of IP exemption, but mostly on the distraction from an imminent issue rather than expanding short-term production capacity through licensing agreements and technology sharing. I agree.

But it is to hold the EU accountable, increase production and come up with industrial solutions to share its own supply. This is due to significant expansion with developing countries later this year. There is a controversy in the United States regarding the crisis between the rich world and the poor over vaccine supply. But Europe has to offer.

Heather Grabbe, director of the Open Society European Policy Institute in Brussels, said the EU’s message to release vaccines to the world while supplying domestic needs is the instinct of its member governments eager to maintain their supply. It states that it has been compromised by.

“What the EU has achieved is very noteworthy, but they are never completely successful in telling a story,” she says. “It’s because Member States aren’t very interested in telling a collective story.”

History will look more kindly at the success of EU vaccines. But for EU leaders, it feels like a long test.

The EU is a good vaccine man, but somehow looks like a villain

Source link The EU is a good vaccine man, but somehow looks like a villain

Back to top button